This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Identify a suitable first coin by considering use case, risk tolerance, and project fundamentals. This guide offers a simple framework to start investing with confidence.
17,349 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
A State Street strategist says the Fed will cut rates three times in 2026, a view that clashes with current market pr...
Ripple accelerates its global push as it secures licenses and partnerships while the XRP ETF narrative gains traction...
Insider stock moves can be routine or signaling. This article breaks down the facts behind ford's farley sells 6,454,...
Market volatility is back in March 2026, and defensive moves can help. This guide highlights three defensive ETFs wor...
Rental-focused development dominated Q4 2025, with 91,000 rental starts among 96,000 total multifamily starts, a jump...
$200K earner ditches roth to cut college costs by lowering AGI for aid calculations at elite universities. The move h...
Regulators delivered a clearer token framework that moves most digital assets out of presumptive securities. But the ...
Three months into 2026, the 2.8% COLA boosted average benefits to $2,071, but a surge in energy prices and Medicare w...
Curious how millionaires think and act with money? This millionaire interview distills actionable steps, from saving ...
A bold plan unfolds as a European crypto treasury targets triple BTC holdings by buying two specialist firms. The mov...